We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Anthrax Toxin Sabotages the Immune Response

By Biotechdaily staff writers
Posted on 05 Aug 2003
Researchers have found that anthrax lethal factor (LF) impairs the function of dendritic cells and thereby diminishes the immune system's ability to battle the microbe.

Investigators at Emory University (Atlanta, GA, USA) studied the effect of LF on immune dendritic cells rather than on macrophages as had been done previously. More...
They reported in the July 17, 2003, issue of Nature that dendritic cells exposed to LF and then stimulated with lipopolysaccharide did not upregulate co-stimulatory molecules, secreted greatly diminished amounts of proinflammatory cytokines, and did not effectively stimulate antigen-specific T-cells in vivo. Furthermore, injections of LF induced a profound impairment of antigen-specific T- and B-cell immunity.

"This is the first study that demonstrates any interaction between Bacillus anthracis and dendritic cells,” explained senior author Dr. Bali Pulendran, associate professor of pathology at Emory University. "Our findings reveal a novel mechanism of action by which the microbe targets the host-immune reaction. When a person is infected with a microbe, we count on the immune system to begin fighting the foreign substance immediately. When the dendritic cells are compromised, such as in our study with the anthrax lethal factor, the innate immune system is unable to stimulate the immune response, thus permitting the microbe to spread unchecked.”




Related Links:
Emory University

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.